Market Cap
US$2.7b
Last Updated
2019/09/14 23:33 UTC
Data Sources
Company Financials +
Executive Summary
Cabot Corporation operates as a specialty chemicals and performance materials company.
Snowflake
Fundamentals
Established dividend payer with proven track record.
Similar Companies
Share Price & News
How has Cabot's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
12.0%
NYSE:CBT
3.8%
US Chemicals
1.2%
US Market
1 Year Return
-25.0%
NYSE:CBT
-11.7%
US Chemicals
1.7%
US Market
CBT underperformed the Chemicals industry which returned -11.7% over the past year.
CBT underperformed the Market in United States of America which returned 1.7% over the past year.
Share holder returns
| CBT | Industry | Market | |
|---|---|---|---|
| 7 Day | 12.0% | 3.8% | 1.2% |
| 30 Day | 25.3% | 5.5% | 4.9% |
| 90 Day | 3.9% | 1.6% | 3.7% |
| 1 Year | -22.6%-25.0% | 2.2%-11.7% | 3.9%1.7% |
| 3 Year | 1.8%-5.6% | 45.7%18.7% | 47.2%37.7% |
| 5 Year | -2.2%-13.3% | 37.1%7.0% | 60.0%42.4% |
Price Volatility Vs. Market
How volatile is Cabot's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Why I Like Cabot Corporation (NYSE:CBT)1 week ago | Simply Wall St
When Should You Buy Cabot Corporation (NYSE:CBT)?3 weeks ago | Simply Wall St
Cabot Corporation (NYSE:CBT) Looks Interesting, And It's About To Pay A DividendValuation
Is Cabot undervalued based on future cash flows and its price relative to the stock market?
17%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
Cabot's share price is below the future cash flow value, but not at a moderate discount (< 20%).
Cabot's share price is below the future cash flow value, but not at a substantial discount (< 40%).
Price Based on Earnings
Cabot is good value based on earnings compared to the US Chemicals industry average.
Cabot is good value based on earnings compared to the United States of America market.
Price Based on Expected Growth
Cabot is good value based on expected growth next year.
Price Based on Value of Assets
Cabot is overvalued based on assets compared to the US Chemicals industry average.
Next Steps
Future Growth
How is Cabot expected to perform in the next 1 to 3 years based on estimates from 5 analysts?
14.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
Cabot's revenue is expected to grow by 2.7% yearly, however this is not considered high growth (20% yearly).
Cabot's earnings are expected to grow by 14.7% yearly, however this is not considered high growth (20% yearly).
Cabot's revenue growth is positive but not above the United States of America market average.
Cabot's earnings growth is expected to exceed the United States of America market average.
Cabot's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
Cabot is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
Next Steps
Past Performance
How has Cabot performed over the past 5 years?
10.4%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Cabot's year on year earnings growth rate has been positive over the past 5 years.
Cabot has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
Cabot has become profitable in the last year making it difficult to compare the US Chemicals industry average.
Return on Equity
Cabot has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
Return on Assets
Cabot used its assets more efficiently than the US Chemicals industry average last year based on Return on Assets.
Return on Capital Employed
Cabot has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is Cabot's financial position?
Financial Position Analysis
Cabot is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Cabot's cash and other short term assets cover its long term commitments.
Debt to Equity History and Analysis
Cabot's level of debt (90.2%) compared to net worth is high (greater than 40%).
The level of debt compared to net worth has increased over the past 5 years (54% vs 90.2% today).
Debt is well covered by operating cash flow (29%, greater than 20% of total debt).
Interest payments on debt are well covered by earnings (EBIT is 7.8x coverage).
Balance Sheet
High level of physical assets or inventory.
Debt is covered by short term assets, assets are 1.2x debt.
Next Steps
Dividend
What is Cabot's current dividend yield, its reliability and sustainability?
2.95%
Expected Dividend Yield
Dividend Yield and Payments Analysis
Cabot's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).
Cabot's dividend is below the markets top 25% of dividend payers in United States of America (3.67%).
Dividends per share have been stable in the past 10 years.
Dividends per share have increased over the past 10 years.
Current Payout to Shareholders
Dividends paid are well covered by earnings (2.7x coverage).
Future Payout to Shareholders
Dividends after 3 years are expected to be well covered by earnings (3.3x coverage).
Next Steps
Management
What is the CEO of Cabot's salary, the management and board of directors tenure and is there insider trading?
2.8yrs
Average management tenure
CEO
Sean Keohane (52yo)
3.5yrs
Tenure
US$6,775,442
Compensation
Mr. Sean D. Keohane serves as Director of Chemours Company since May 3, 2018. He has been the Chief Executive Officer and President of Cabot Corporation since March 11, 2016. Mr. Keohane served as an Execu ...
CEO Compensation Analysis
Sean's remuneration is higher than average for companies of similar size in United States of America.
Sean's compensation has increased in line with Cabot recently becoming profitable.
Management Age and Tenure
2.8yrs
Average Tenure
50.5yo
Average Age
The tenure for the Cabot management team is about average.
Board Age and Tenure
6.1yrs
Average Tenure
63.5yo
Average Age
The tenure for the Cabot board of directors is about average.
Insider Trading
No 3 month open market individual insider trading information.
Ownership Breakdown
Management Team
Patrick Prevost (64yo)
Advisor & Director
- Tenure: 11.7yrs
- Compensation: US$194.45k
Martin O'Neill
Senior VP of Safety
- Tenure: 2.2yrs
Sean Keohane (52yo)
President
- Tenure: 3.5yrs
- Compensation: US$6.78m
Steven Delahunt
VP of Investor Relations & Treasurer
- Tenure: 3.2yrs
Erica McLaughlin (43yo)
Senior VP & CFO
- Tenure: 1.3yrs
- Compensation: US$1.24m
Jeff Zhu
Senior VP & President of Asia Pacific Region
- Tenure: 7.4yrs
Bart Kalkstein (49yo)
Senior VP
- Tenure: 3.4yrs
- Compensation: US$1.71m
Art Wood
Senior VP & Chief Human Resources Officer
- Tenure: 2.4yrs
Patricia Hubbard
Senior VP & CTO
- Tenure: 1.6yrs
Karen Kalita
Senior VP & General Counsel
- Tenure: 0.7yrs
Board Members
John O'Brien (75yo)
Independent Non-Executive Director
- Tenure: 29.7yrs
- Compensation: US$249.56k
Mark Wrighton (69yo)
Independent Director
- Tenure: 22.7yrs
- Compensation: US$208.37k
Matthias Wolfgruber (65yo)
Independent Director
- Tenure: 5yrs
- Compensation: US$209.17k
Patrick Prevost (64yo)
Advisor & Director
- Tenure: 11.7yrs
- Compensation: US$194.45k
Juan Enriquez (59yo)
Independent Director
- Tenure: 14.5yrs
- Compensation: US$209.88k
Sean Keohane (52yo)
President
- Tenure: 3.5yrs
- Compensation: US$6.78m
Cynthia Arnold (62yo)
Independent Director
- Tenure: 1.7yrs
- Compensation: US$178.51k
Bill Kirby (68yo)
Independent Director
- Tenure: 7.2yrs
- Compensation: US$218.37k
Sue Rataj (62yo)
Non-Executive Chairman
- Tenure: 1.5yrs
- Compensation: US$267.09k
Mike Morrow (63yo)
Independent Director
- Tenure: 2yrs
- Compensation: US$208.01k
Company Information
Cabot Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Cabot Corporation
- Ticker: CBT
- Exchange: NYSE
- Founded: 1882
- Industry: Commodity Chemicals
- Sector: Materials
- Market Cap: US$2.729b
- Shares outstanding: 57.78m
- Website: https://www.cabotcorp.com
Number of Employees
Location
- Cabot Corporation
- Two Seaport Lane
- Suite 1300
- Boston
- Massachusetts
- 2210
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CBT | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Aug 1968 |
| CBT | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1968 |
Biography
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/09/14 23:33 |
| End of Day Share Price | 2019/09/13 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/09/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.